Skip to content

Abnormal Circulating Reverse T3 Concentration C6055352

Published: July 22, 2026Updated: August 25, 2026

Reverse T3 is an inactive form of thyroid hormone. Abnormal levels often occur during severe illness or chronic disease and may affect metabolism. Treatment focuses on the underlying condition.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
E34.9
ICD-11
5A00.0
Body system
endocrine
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Hypotension

Abnormally low blood pressure that may cause dizziness or lightheadedness.

Seek emergency care for severe hypotension with fainting, confusion, or difficulty breathing.

Fatigue

(constitutional)

Persistent tiredness and lack of energy that is not relieved by rest.

Frequency: 70-80% of patients

Cold intolerance

(constitutional)

Feeling unusually cold, especially in the hands and feet, due to slowed metabolism.

Frequency: 50-60% of patients

Bradycardia

(cardiovascular)

Abnormally slow heart rate, typically below 60 beats per minute.

Frequency: 40-50% of patients

Constipation

(gastrointestinal)

Infrequent bowel movements with difficulty passing stools.

Frequency: 40-50% of patients

Dry skin

(dermatologic)

Rough, flaky, or itchy skin that may appear pale or cool to the touch.

Frequency: 35-45% of patients

Cognitive impairment

(neurologic)

Difficulty with concentration, memory problems, or mental fogginess.

Frequency: 15-25% of patients

Weight gain

(constitutional)

Unexplained increase in body weight, often modest and due to fluid retention and slowed metabolism.

Frequency: 40-50% of patients

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Endocrine management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Thyroid Function Monitoring

Regular monitoring of thyroid hormones including reverse T3, T3, T4, and TSH to assess thyroid status and track changes over time.

monitoring
3

Stress Reduction and Sleep Optimization

Implementation of stress management techniques including mindfulness, relaxation exercises, and sleep hygiene practices to support healthy thyroid hormone conversion.

lifestyle

Additional treatment options

Nutritional Support for Thyroid Function

Dietary modifications emphasizing selenium-rich foods, adequate protein intake, and avoidance of goitrogens to support optimal thyroid hormone metabolism.

dietary

Thyroid Hormone Replacement Therapy

If underlying hypothyroidism is confirmed, thyroid hormone replacement may be considered based on comprehensive thyroid assessment and clinical symptoms.

medication

Adrenal Support Protocol

Support for adrenal function through adaptogenic herbs and stress reduction, as adrenal dysfunction can affect reverse T3 metabolism and thyroid hormone conversion.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Abnormal Circulating Reverse T3 Concentration C6055352?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Ross DS, Burch HB, Cooper DS, Greenlee MC, Laurberg P, Maia AL, Rivkees SA, Samuels M, Sosa JA, Stanici MN, Walter MA. 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis. Thyroid. 2016;26(10):1343-1421.

guideline2016View source →
2

Warner MH, Beckett GJ. Mechanisms behind the non-thyroidal illness syndrome: an update. J Endocrinol. 2010;205(1):1-13.

review2010View source →
3

Chatzitomaris A, Hoermann R, Midgley JE, Hering S, Urban A, Dietrich B, Abood A, Klein HH, Dietrich JW. Thyroid Allostasis-Adaptive Responses of Thyroid Hormone System During Diseases and Beyond. Front Endocrinol (Lausanne). 2017;8:161.

review2017View source →
4

Jonklaas J, Bianco AC, Bauer AJ, Burman KD, Cappola AR, Celi FS, Cooper DS, Kim BW, Peeters RP, Rosenthal MS, Sawka AM. Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement. Thyroid. 2014;24(12):1670-1751.

guideline2014View source →
5

Fliers E, Bianco AC, Langouche L, Boelen A. Thyroid function in critically ill patients. Lancet Diabetes Endocrinol. 2015;3(10):816-825.

review2015View source →
6

van de Sande SA, Diness BL, Ertl C, Witte CU, Liu D, van der Geyten S, Leuschner G, Gurnsey M, Langouche L, Boelen A. Reverse T3 as a member of the 3,5,3'-triiodothyronine regulatory network: a systematic review. Eur Thyroid J. 2023;12(2):e220155.

meta_analysis2023View source →
7

Demers LM, Spencer CA. Laboratory Medicine Practice Guidelines: Laboratory Support for the Diagnosis and Monitoring of Thyroid Disease. Clin Endocrinol (Oxf). 2003;58(2):138-155.

position_statement2003View source →
8

Peeters RP, van der Geyten S, Wouters PJ, Darras VM, Toet H, Van Herck E, Van den Berghe G. Tissue thyroid hormone levels in critical illness. J Clin Endocrinol Metab. 2005;90(12):6402-6409.

clinical_trial2005View source →
9

McIver B, Gorman CA. Euthyroid sick syndrome: an overview. Thyroid. 1997;7(1):125-132.

review1997View source →
10

Bianco AC, Salvatore D, Gereben B, Berry MJ, Larsen PR. Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr Rev. 2002;23(1):38-89.

consensus2002View source →

Medication Comparisons

Compare medications used to treat Abnormal Circulating Reverse T3 Concentration C6055352. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy